Jennewein Biotechnologie GmbH
L-Fucose -Sweet Key to a Youthful Skin
(DGAP-Media / 03.12.2012 / 08:00)
Environmentally friendly and cost effective production for active
anti-aging ingredient developed
With increasing age the human skin shows a considerable loss of resistance
and elasticity. These changes in skin texture, which are one of the main
reasons for the appearance of wrinkles, is the age induced loss of skin
thickness and the related degradation of elastin fibers within the skin. It
has been proven that L-Fucose - a scarce sugar - slows down and even
reverses age-related skin developments.
Dermatological studies have shown that the application of an L-Fucose
containing skin-cream leads to a considerable increase in skin thickness
and elasticity. Soluble L-Fucose penetrates rapidly in the epidermis and
deeper layers of the dermis where it assumes several beneficial functions.
For instance, L-Fucose inhibits the production of enzymes which provoke the
loss of skin thickness. Furthermore, L-Fucose stimulates the proliferation
of fibroblasts - special skin cells which play a key role in the production
of elastic fibers and wound healing. Hence, by applying L-Fucose the skin
becomes more resistant, shows fewer wrinkles and exhibits an improvement on
wound healing and skin elasticity.
After several years of research and development, Jennewein Biotechnologie
has achieved a major milestone in the production of this active ingredient.
L-Fucose is produced with the help of a sustainable biological production
process. Klaus Jennewein, managing director marketing and sales,
emphasizes, ´The multi-functional ingredient L-Fucose responds not only to
the demand for new active ingredients for the use in cosmetic products but
also reflects the trend to produce cosmetic ´high-tech active molecules´ in
an environmentally friendly and cost effective manner´.
The patent protected production process allows for:
- the provisioning of a natural product / sugar,
- a cost effective production associated with attractive prices,
- the use of a sustainable and environmentally friendly production
process.
L-Fucose is a scarce sugar which can be found in nature in selected plants
and in various organs of the human body, such as the skin, for example. Due
to the high effectiveness, small concentrations of L-Fucose lead to a
considerable positive and visible effect after a short period of
application. Fields of use of L-Fucose are anti-aging, sensitive skin-care
and wound healing.
About Jennewein Biotechnologie
Jennewein Biotechnologie is a family owned business concentrating on the
production of functional ingredients for the food, personal care and
pharmaceutical industry. The product L-Fucose is commercialized by selected
partners such as IMPAG in Germany, Austria and Switzerland, Laserson in
France, Monaco and Switzerland, OpalBond in UK and Ireland as well as
Interlees and Beauty & Health Works in South Korea.
Further information and graphical material can be found in the internet or
by writing to:
Jennewein Biotechnologie GmbH
Maarweg 32
D-53619 Rheinbreitbach
Germany
Tel.: +49-2224-989.4502
Fax.: +49-2224-988.0854
EMail: info@jennewein-biotech.de
End of Media Release
Issuer: Jennewein Biotechnologie GmbH
Key word(s): Health
03.12.2012 Dissemination of a Press Release, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP´s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
195322 03.12.2012
containing skin-cream leads to a considerable increase in skin thickness
and elasticity. Soluble L-Fucose penetrates rapidly in the epidermis and
deeper layers of the dermis where it assumes several beneficial functions.
For instance, L-Fucose inhibits the production of enzymes which provoke the
loss of skin thickness. Furthermore, L-Fucose stimulates the proliferation
of fibroblasts - special skin cells which play a key role in the production
of elastic fibers and wound healing. Hence, by applying L-Fucose the skin
becomes more resistant, shows fewer wrinkles and exhibits an improvement on
wound healing and skin elasticity.
After several years of research and development, Jennewein Biotechnologie
has achieved a major milestone in the production of this active ingredient.
L-Fucose is produced with the help of a sustainable biological production
process. Klaus Jennewein, managing director marketing and sales,
emphasizes, ´The multi-functional ingredient L-Fucose responds not only to
the demand for new active ingredients for the use in cosmetic products but
also reflects the trend to produce cosmetic ´high-tech active molecules´ in
an environmentally friendly and cost effective manner´.
The patent protected production process allows for:
- the provisioning of a natural product / sugar,
- a cost effective production associated with attractive prices,
- the use of a sustainable and environmentally friendly production
process.
L-Fucose is a scarce sugar which can be found in nature in selected plants
and in various organs of the human body, such as the skin, for example. Due
to the high effectiveness, small concentrations of L-Fucose lead to a
considerable positive and visible effect after a short period of
application. Fields of use of L-Fucose are anti-aging, sensitive skin-care
and wound healing.
About Jennewein Biotechnologie
Jennewein Biotechnologie is a family owned business concentrating on the
production of functional ingredients for the food, personal care and
pharmaceutical industry. The product L-Fucose is commercialized by selected
partners such as IMPAG in Germany, Austria and Switzerland, Laserson in
France, Monaco and Switzerland, OpalBond in UK and Ireland as well as
Interlees and Beauty & Health Works in South Korea.
Further information and graphical material can be found in the internet or
by writing to:
Jennewein Biotechnologie GmbH
Maarweg 32
D-53619 Rheinbreitbach
Germany
Tel.: +49-2224-989.4502
Fax.: +49-2224-988.0854
EMail: info@jennewein-biotech.de
End of Media Release
Issuer: Jennewein Biotechnologie GmbH
Key word(s): Health
03.12.2012 Dissemination of a Press Release, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP´s Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
195322 03.12.2012